Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Barbara L Andersen"'
Autor:
Barbara L Andersen, John Myers, Tessa Blevins, Kylie R Park, Rachel M Smith, Sarah Reisinger, David P Carbone, Carolyn J Presley, Peter G Shields, William E Carson
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0282206 (2023)
Lung cancer is a product of inflammation and a dysfunctional immune system, and depression has similar dysregulation. Depression disproportionately affects lung cancer patients, having the highest rates of all cancers. Systemic inflammation and depre
Externí odkaz:
https://doaj.org/article/f40278a7ccd64d939105c58ed313b0ee
Publikováno v:
Journal of Cancer Rehabilitation, Vol 5, Iss 1, Pp 69-76 (2022)
Background Patients with advanced lung cancer experience severe and distressing symptoms, especially anxiety, breathlessness, insomnia, pain, and fatigue. Progressive muscle relaxation (PMR) is an empirically supported treatment for reducing psycholo
Externí odkaz:
https://doaj.org/article/68257733c06648caa50ddd4b349f9a9e
Autor:
Barbara L. Andersen, Rebecca A. Shelby
Publikováno v:
Journal of Cancer Rehabilitation, Vol 4, Iss 1, Pp 295-302 (2021)
Sexuality in cancer patients has been studied for at least 70 years, with the earliest work done by oncologists comparing outcomes of patients receiving different treatments. However, Masters’ and Johnson’s studies of sexuality (1966) and sexual
Externí odkaz:
https://doaj.org/article/a4d1e0e35e3840e186342ad98453c793
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/ee398cf6b53047d8aadac122f95aadec
Autor:
Carolyn J. Presley, MD, MHS, Nicole A. Arrato, MA, Peter G. Shields, MD, David P. Carbone, MD, PhD, Melisa L. Wong, MD, MAS, Jason Benedict, MS, Sarah A. Reisinger, PhD, MPH, Ling Han, MD, PhD, Thomas M. Gill, MD, Heather Allore, PhD, Barbara L. Andersen, PhD, Sarah Janse, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 6, Pp 100334- (2022)
Introduction: To evaluate whether and the degree to which patients with advanced NSCLC (aNSCLC) receiving lung cancer treatments will experience functional disability or have resilience and to identify characteristics associated with functional disab
Externí odkaz:
https://doaj.org/article/84faa37665c74d2f8168f0438710b653
Autor:
Jean-Loup Mouysset, David Spiegel, Barbara L. Andersen, Emmanuel Kinne, Pierre Caillat, Laetiia Dewolf, Chantal Zedet Saunders, Nancie Rosati, Thierry Bouillet, Antoine Demonceaux, Philippe Orts, Jean Yves Blay
Publikováno v:
Journal of Cancer Rehabilitation, Vol 3, Iss 1, Pp 20-27 (2020)
Objectives There is still no structured psychosocial intervention (SPI) available in France for patients with metastatic disease. For first time in France, a structured psychosocial intervention (SPI) was proposed and studied as “proof of concep
Externí odkaz:
https://doaj.org/article/4099ca70e7d74eec96f86e2ba4119867
Publikováno v:
Journal of Cancer Rehabilitation, Vol 2, Iss 1, Pp 24-29 (2019)
Lung cancer is the leading cause of cancer-related death worldwide with non-small cell lung cancer (NSCLC) being the most common type. Advanced NSCLC is not curable and carries a poor prognosis. It also is associated with the highest burden on ment
Externí odkaz:
https://doaj.org/article/9f07174902924f80b3f29b1701000c59
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-3 (2019)
Externí odkaz:
https://doaj.org/article/b7ed20e7e09c4d1a8251c0b9d5de4175
Autor:
Thomas R. Valentine, Carolyn J. Presley, David P. Carbone, Peter G. Shields, Barbara L. Andersen
Publikováno v:
Health Psychol
Of all cancers, advanced nonsmall cell lung cancer (NSCLC) is associated with the highest burden on mental and physical health-related quality of life (HRQoL). Patients' subjective beliefs about their cancer (i.e., illness perceptions) may influence
Autor:
Andrew C Johns, Mike Yang, Lai Wei, Madison Grogan, Daniel Spakowicz, Sandipkumar H Patel, Mingjia Li, Marium Husain, Kari L Kendra, Gregory A Otterson, Ashley E Rosko, Barbara L Andersen, David P Carbone, Dwight H Owen, Carolyn J Presley
Publikováno v:
The Oncologist.
Objectives Immune checkpoint inhibitor immunotherapy (IO) is revolutionizing cancer care but can lead to significant toxicity. This study seeks to describe potential risk factors for immune-related adverse events (irAEs) specifically among older adul